Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Virtual Pathology Image Company Opens, Raises $15.2M

Breast cancer cells, microscope image

A developer of virtual tissue staining systems aided by algorithms for medical images began public operations today, raising $15.2 million in venture funds. . . . → Read More: Virtual Pathology Image Company Opens, Raises $15.2M

Biotech, Regeneron in $2B Cancer Antibody Deal

Cancer magnified

A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies. . . . → Read More: Biotech, Regeneron in $2B Cancer Antibody Deal

Residual Cancer Detection Company Launches, Raises $56M

Blood vials

A start-up enterprise developing personalized liquid biopsies for finding residual cancer in patients is beginning work and raising $56 million in venture funds. . . . → Read More: Residual Cancer Detection Company Launches, Raises $56M

Biotech, M.D. Anderson Partner on Precision Drug Design

Network pointer

A company discovering therapies with artificial intelligence is partnering with M.D. Anderson Cancer Center on new small-molecule precision medicines. . . . → Read More: Biotech, M.D. Anderson Partner on Precision Drug Design

Patent Awarded for Focused Ultrasound Skin Treatments

U.S. Patent and Trademark Office

A company developing non-invasive ultrasound treatments for treating skin disorders and removing tattoos received a patent for its technology. . . . → Read More: Patent Awarded for Focused Ultrasound Skin Treatments

Trial Shows Results for Personal Cancer Immunotherapies

DNA plasmid illustration

Interim results from a clinical trial testing personalized therapies invoking the immune system show responses from some patients with advanced liver cancer. . . . → Read More: Trial Shows Results for Personal Cancer Immunotherapies

Cancer Detection Start-Up Gains $4M in Seed Funds

Detect cancer scrabble

A developer of early-stage non-invasive cancer detection tests based on research in university labs is raising $4 million in its seed venture round. . . . → Read More: Cancer Detection Start-Up Gains $4M in Seed Funds

AI Analytics Boost Breast Cancer Assessment Diversity

Breast cancer cell

A genomic analytics company says an ethnicity algorithm added to a personal health questionnaire improves risk assessments for breast cancer across all populations. . . . → Read More: AI Analytics Boost Breast Cancer Assessment Diversity

Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors

Breast tumor microenvironment

Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment. . . . → Read More: Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors

Immunotherapy Start-Up Launches Collaboration, Raises $65M

T-cells and cancer cells

A new biotechnology company is creating cancer immunotherapies that it says harness more of the full power of T-cells in the immune system to attack tumors. . . . → Read More: Immunotherapy Start-Up Launches Collaboration, Raises $65M